Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Beleites

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
HNO|July 17, 2004
[Thermal irritation of the organ of equilibrium by means of heat radiation (NIR)]L E Walther, A Scheibe, W-D Schmidt, et al.
International Journal of Molecular Medicine|July 30, 1999
P53 genotyping - an effective concept for molecular testing of head and neck cancer?R Dahse, W Fiedler, F von Eggeling, et al.
HNO|January 20, 2005
[Infectious mononucleosis]L E Walther, J Ilgner, A Oehme, et al.
Laryngo- Rhino- Otologie|November 1, 2003
[Near infrared stimulation of the equilibrium organ--first clinical experiences]L E Walther, W-D Schmidt, H Gudziol, et al.
International Journal of Molecular Medicine|June 22, 1999
Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancerU Riese, R Dahse, W Fiedler, et al.
Otolaryngologia Polska = the Polish Otolaryngology|August 5, 2000
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancerS Koscielny, R Dahse, J Sonntag, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
HNO|July 17, 2004
[Thermal irritation of the organ of equilibrium by means of heat radiation (NIR)]L E Walther, A Scheibe, W-D Schmidt, et al.
International Journal of Molecular Medicine|July 30, 1999
P53 genotyping - an effective concept for molecular testing of head and neck cancer?R Dahse, W Fiedler, F von Eggeling, et al.
HNO|January 20, 2005
[Infectious mononucleosis]L E Walther, J Ilgner, A Oehme, et al.
Laryngo- Rhino- Otologie|November 1, 2003
[Near infrared stimulation of the equilibrium organ--first clinical experiences]L E Walther, W-D Schmidt, H Gudziol, et al.
International Journal of Molecular Medicine|June 22, 1999
Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancerU Riese, R Dahse, W Fiedler, et al.
Otolaryngologia Polska = the Polish Otolaryngology|August 5, 2000
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancerS Koscielny, R Dahse, J Sonntag, et al.
Pageof 3